Notes and Summary: Experiment Exception and Patent Tool Amy Zhe Peng 0734664 The Evolution of A Patent Infringement Dispute: Merck KGaA V. Integra Life Sciences Guest Lecture: Ms. Cathryn Campbell IP Innovation Class April 7 20008 Merck KGaA V. Integra Life is decided by the U.S. Supreme Court on June 13, 2005. It is a crucial case involving the scope of the research use exemption under 35 U.S.C. § 271(e)(1), which allows utilization patent techniques without permission solely for submission of information under federal drug regulation. Ms. Cathryn Campbell, an attorney who worked on this case, went through issues in dispute as well as argument actually occurred in court. The §271(e)(1) research exemption permits persons other than the patent holder to “make, use, offer to sell, or sell within the United States or import into the United States a patented invention (other than a new animal drug or veterinary biological product) . . . solely for uses reasonably related to the development and submission of information under a Federal law which regulates the
This is the end of the preview. Sign up
access the rest of the document.
This note was uploaded on 08/27/2008 for the course LAW P E589 taught by Professor O'conor during the Spring '08 term at University of Washington.